R Morrow

Summary

Affiliation: University of Washington
Country: USA

Publications

  1. pmc Performance of the focus and Kalon enzyme-linked immunosorbent assays for antibodies to herpes simplex virus type 2 glycoprotein G in culture-documented cases of genital herpes
    Rhoda Ashley Morrow
    University of Washington Department of Laboratory Medicine, Children s Hospital and Regional Medical Center, Seattle, Washington 98195, USA
    J Clin Microbiol 41:5212-4. 2003
  2. ncbi request reprint Performance of focus ELISA tests for herpes simplex virus type 1 (HSV-1) and HSV-2 antibodies among women in ten diverse geographical locations
    R Ashley-Morrow
    Department of Laboratory Medicine, University of Washington, Seattle, Washington 98105, USA
    Clin Microbiol Infect 10:530-6. 2004
  3. ncbi request reprint Development and use of a type-specific antibody avidity test based on herpes simplex virus type 2 glycoprotein G
    Rhoda Ashley Morrow
    Department of Laboratory Medicine, The University of Washington, Seattle, Washington, USA
    Sex Transm Dis 31:508-15. 2004
  4. pmc Use of "biokit HSV-2 Rapid Assay" to improve the positive predictive value of Focus HerpeSelect HSV-2 ELISA
    Rhoda Ashley Morrow
    Department of Laboratory Medicine, University of Washington, Seattle, Washington, USA
    BMC Infect Dis 5:84. 2005
  5. ncbi request reprint Performance of a novel test for IgM and IgG antibodies in subjects with culture-documented genital herpes simplex virus-1 or -2 infection
    R Morrow
    Department of Laboratory Medicine, University of Washington, Children s Hospital and Regional Medical Center, 4800 Sand Point Way NE, Seattle, WA 98105, USA
    Clin Microbiol Infect 12:463-9. 2006
  6. ncbi request reprint Clinical correlates of index values in the focus HerpeSelect ELISA for antibodies to herpes simplex virus type 2 (HSV-2)
    Rhoda Ashley Morrow
    University of Washington, Department of Laboratory Medicine, USA
    J Clin Virol 36:141-5. 2006
  7. pmc Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2
    C Celum
    Department of Global Health, University of Washington, Harborview Medical Center, 325 Ninth Ave, Box 359927, Seattle, WA 98104, USA
    N Engl J Med 362:427-39. 2010

Detail Information

Publications7

  1. pmc Performance of the focus and Kalon enzyme-linked immunosorbent assays for antibodies to herpes simplex virus type 2 glycoprotein G in culture-documented cases of genital herpes
    Rhoda Ashley Morrow
    University of Washington Department of Laboratory Medicine, Children s Hospital and Regional Medical Center, Seattle, Washington 98195, USA
    J Clin Microbiol 41:5212-4. 2003
    ..Median times to seroconversion were 120 days by the Kalon assay, 21 days by the Focus assay, and 68 days by Western blotting assay. Values for specificity were 100% (Kalon) and 93% (Focus)...
  2. ncbi request reprint Performance of focus ELISA tests for herpes simplex virus type 1 (HSV-1) and HSV-2 antibodies among women in ten diverse geographical locations
    R Ashley-Morrow
    Department of Laboratory Medicine, University of Washington, Seattle, Washington 98105, USA
    Clin Microbiol Infect 10:530-6. 2004
    ..In summary, the sensitivity and specificity of the Focus-HSV-1 and Focus-HSV-2 tests varied by site. Performance data generated in one area may not be applicable to other populations...
  3. ncbi request reprint Development and use of a type-specific antibody avidity test based on herpes simplex virus type 2 glycoprotein G
    Rhoda Ashley Morrow
    Department of Laboratory Medicine, The University of Washington, Seattle, Washington, USA
    Sex Transm Dis 31:508-15. 2004
    ..It is difficult to discriminate between lesions resulting from recently acquired versus established genital herpes simplex virus type 2 (HSV-2) infection. Methods not based on history or serum IgM status are needed...
  4. pmc Use of "biokit HSV-2 Rapid Assay" to improve the positive predictive value of Focus HerpeSelect HSV-2 ELISA
    Rhoda Ashley Morrow
    Department of Laboratory Medicine, University of Washington, Seattle, Washington, USA
    BMC Infect Dis 5:84. 2005
    ....
  5. ncbi request reprint Performance of a novel test for IgM and IgG antibodies in subjects with culture-documented genital herpes simplex virus-1 or -2 infection
    R Morrow
    Department of Laboratory Medicine, University of Washington, Children s Hospital and Regional Medical Center, 4800 Sand Point Way NE, Seattle, WA 98105, USA
    Clin Microbiol Infect 12:463-9. 2006
    ..Addition of IgM testing substantially increased the ability to detect seroconversion early in infection. IgM is an indicator of recent infection only in subjects who lack detectable IgG...
  6. ncbi request reprint Clinical correlates of index values in the focus HerpeSelect ELISA for antibodies to herpes simplex virus type 2 (HSV-2)
    Rhoda Ashley Morrow
    University of Washington, Department of Laboratory Medicine, USA
    J Clin Virol 36:141-5. 2006
    ..Clinical correlates of HerpeSelect ELISA index values are poorly understood...
  7. pmc Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2
    C Celum
    Department of Global Health, University of Washington, Harborview Medical Center, 325 Ninth Ave, Box 359927, Seattle, WA 98104, USA
    N Engl J Med 362:427-39. 2010
    ..Therapy to suppress HSV-2 reduces the frequency of reactivation of HSV-2 as well as HIV-1 levels, suggesting that suppression of HSV-2 may reduce the risk of transmission of HIV-1...